Novel coronavirus disease 2019 (COVID-19) non-respiratory involvement

Sobh, Eman; Abuarrah, Einas; Abdelsalam, Khloud Gamal; Awad, Sohaila Sabry; Badawy, Mohamed A.; Fathelbab, Mohamed A.; Aboulfotouh, Mohamed; Awadallah, Mohamed Fawzi

doi:10.1186/s43168-020-00030-1

Cited by 4 publications

(2 citation statements)

References 66 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, most keywords were related to respiratory issues, which were the most common symptoms during the early waves of COVID-19 [ 32 ]. More recent studies have reported nonrespiratory symptoms of COVID-19 [ 33 - 36 ] that we incorporated, but we were unable to use a more accurate method, such as COVID-19 test results to evaluate how the recurring pandemic waves relate to telemedicine use. Additionally, satisfaction data were only available for VUC visits.…”

Section: Discussionmentioning

confidence: 99%

Evidence for Telemedicine’s Ongoing Transformation of Health Care Delivery Since the Onset of COVID-19: Retrospective Observational Study

Mandal¹,

Wiesenfeld²,

Mann³

et al. 2022

JMIR Form Res

View full text Add to dashboard Cite

Background The surge of telemedicine use during the early stages of the COVID-19 pandemic has been well documented. However, scarce evidence considers the use of telemedicine in the subsequent period. Objective This study aims to evaluate use patterns of video-based telemedicine visits for ambulatory care and urgent care provision over the course of recurring pandemic waves in 1 large health system in New York City (NYC) and what this means for health care delivery. Methods Retrospective electronic health record (EHR) data of patients from January 1, 2020, to February 28, 2022, were used to longitudinally track and analyze telemedicine and in-person visit volumes across ambulatory care specialties and urgent care, as well as compare them to a prepandemic baseline (June-November 2019). Diagnosis codes to differentiate suspected COVID-19 visits from non–COVID-19 visits, as well as evaluating COVID-19–based telemedicine use over time, were compared to the total number of COVID-19–positive cases in the same geographic region (city level). The time series data were segmented based on change-point analysis, and variances in visit trends were compared between the segments. Results The emergence of COVID-19 prompted an early increase in the number of telemedicine visits across the urgent care and ambulatory care settings. This use continued throughout the pandemic at a much higher level than the prepandemic baseline for both COVID-19 and non–COVID-19 suspected visits, despite the fluctuation in COVID-19 cases throughout the pandemic and the resumption of in-person clinical services. The use of telemedicine-based urgent care services for COVID-19 suspected visits showed more variance in response to each pandemic wave, but telemedicine visits for ambulatory care have remained relatively steady after the initial crisis period. During the Omicron wave, the use of all visit types, including in-person activities, decreased. Patients between 25 and 34 years of age were the largest users of telemedicine-based urgent care. Patient satisfaction with telemedicine-based urgent care remained high despite the rapid scaling of services to meet increased demand. Conclusions The trend of the increased use of telemedicine as a means of health care delivery relative to the pre–COVID-19 baseline has been maintained throughout the later pandemic periods despite fluctuating COVID-19 cases and the resumption of in-person care delivery. Overall satisfaction with telemedicine-based care is also high. The trends in telemedicine use suggest that telemedicine-based health care delivery has become a mainstream and sustained supplement to in-person-based ambulatory care, particularly for younger patients, for both urgent and nonurgent care needs. These findings have implications for the health care delivery system, including practice leaders, insurers, and policymakers. Further investigation is needed to evaluate telemedicine adoption by key demographics, identify ongoing barriers to adoption, and explore the impacts of sustained use of telemedicine on health care outcomes and experience.

show abstract

Section: Discussionmentioning

confidence: 99%

Evidence for Telemedicine’s Ongoing Transformation of Health Care Delivery Since the Onset of COVID-19: Retrospective Observational Study

Mandal¹,

Wiesenfeld²,

Mann³

et al. 2022

JMIR Form Res

View full text Add to dashboard Cite

show abstract

“…9 Poor outcomes in COVID-19 were linked to severe respiratory involvement, cardiac, and renal involvement. 10 Previous reports showed that comorbidities like COPD, and diabetes mellitus were linked to poor outcomes. 11 Significant independent potential predictors of in-hospital mortality were reported in elderly COVID-19 patients including hypernatremia [HR 9.1], lymphopenia [HR7.4], and cardiovascular disease (CVD) other than hypertension [HR6.4].…”

Section: Introductionmentioning

confidence: 99%

Sociodemographic and clinical characteristics of early COVID-19 deaths in Almadinah Almonawarah, Saudi Arabia: An analytical cross-sectional study

Surrati¹,

Sobh²,

Mansuri

et al. 2023

Pak J Med Sci

View full text Add to dashboard Cite

Background and Objective: Identification of clinical characteristics and risk factors for mortality in COVID-19 is important for early detection and precise case management. The study aimed to describe the sociodemographic, clinical, and laboratory characteristics of in-hospital COVID-19 deaths in Almadinah Almonawarah city, Saudi Arabia, and to identify risk factors for early mortality among them. Methods: This is an analytical cross-sectional study. The main outcomes were demographic and clinical characteristics of COVID 19 patients who died from March till December 2020, during the hospital stay. We collected 193 records of COVID-19 patients, from two major hospitals in Al Madinah region, Saudi Arabia. Descriptive and inferential analysis were performed to identify and relate the factors of early death. Results: Out of the total deaths, 110 died during the first 14 days of admission (Early death group) and 83 died after 14 days of admission (Late death group). Early death group had a significantly higher percentages of old age patients (p=0.027) and males (72.7%). Comorbidities were found in 166 (86%) of cases. Multimorbidity were significantly higher in early deaths than in late deaths 74.5% (p=<0.001). Women had significantly higher mean values of CHA2SD2 comorbidity scores (3.28 versus 1.89 for men; p <0.001). Moreover, predictors of high comorbidity scores were older age (p=0.005), higher respiratory rate (p=0.035), and raised alanine transaminase (p=0.047). Conclusion: Old age, comorbid illness, and severe respiratory involvement were prevalent among COVID-19 deaths. Comorbidity scores were significantly higher in women. Comorbidity was found to be significantly more associated with early deaths. doi: https://doi.org/10.12669/pjms.39.3.6736 How to cite this: Surrati AMQ, Sobh E, Mansuri FA, Bokhari AA, Haroon SM, Alewi NM. Sociodemographic and clinical characteristics of early COVID-19 deaths in Almadinah Almonawarah, Saudi Arabia: An analytical cross-sectional study. Pak J Med Sci. 2023;39(3):704-709. doi: https://doi.org/10.12669/pjms.39.3.6736 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

show abstract

Hearing Loss-a Camouflaged Manifestation of COVID 19 Infection

Dharmarajan

Bharathi

Sivapuram

et al. 2021

Indian J Otolaryngol Head Neck Surg

View full text Add to dashboard Cite

The symptomatology of novel Severe Acute Respiratory Syndrome Corona virus type 2 infection runs the entire gamut of mild to moderate and serious illness among the affected individuals. As listed in recent literature, respiratory, cardiovascular, gastrointestinal, olfactory and gustatory systems are commonly involved. With the growing knowledge about the disease, varied manifestations have been identified and lately, otorhinolaryngology dysfunctions in COVID 19 have been described. Hearing loss in COVID era is one of the emerging areas of concern and calls for further research in the field for the better understanding and treatment of this entity. This study was designed to assess the audiological profile among 100 mild to moderately affected COVID-19 individuals, so as to make a contribution to the emerging literature on otologic manifestations in COVID 19. In our case series, high frequency hearing loss and referred OAE was noted among significant number of COVID 19 positive patients. This was even observed in patients without any otologic symptoms. Hence, early identification and intervention if required helps to give a better quality of life to the patient.

show abstract

Novel coronavirus disease 2019 (COVID-19) non-respiratory involvement

Cited by 4 publications

References 66 publications

Evidence for Telemedicine’s Ongoing Transformation of Health Care Delivery Since the Onset of COVID-19: Retrospective Observational Study

Evidence for Telemedicine’s Ongoing Transformation of Health Care Delivery Since the Onset of COVID-19: Retrospective Observational Study

Sociodemographic and clinical characteristics of early COVID-19 deaths in Almadinah Almonawarah, Saudi Arabia: An analytical cross-sectional study

Hearing Loss-a Camouflaged Manifestation of COVID 19 Infection

Contact Info

Product

Resources

About